# Title
Lactonization O
is O
the O
critical O
first O
step O
in O
the O
disposition O
of O
the O
3-hydroxy-3-methylglutaryl-CoA B-Gene
reductase I-Gene
inhibitor O
atorvastatin. B-Chemical

# Abstract
In O
an O
in O
vitro O
study, O
we O
compared O
the O
cytochrome O
P450 O
(CYP)-dependent O
metabolism O
and O
drug O
interactions O
of O
the O
acid O
and O
lactone B-Chemical
forms O
of O
the O
3-hydroxy-3-methylglutaryl B-Gene
(HMG)-CoA I-Gene
reductase I-Gene
inhibitor O
atorvastatin. B-Chemical
Metabolism O
of O
atorvastatin B-Chemical
acid I-Chemical
and O
lactone B-Chemical
by O
human B-Species
liver O
microsomes O
resulted O
in O
para-hydroxy O
and O
ortho-hydroxy O
metabolites. O
Both O
substrates O
were O
metabolized O
mainly O
by O
CYP3A4 B-Gene
and O
CYP3A5. B-Gene
Atorvastatin B-Chemical
lactone B-Chemical
had O
a O
significantly O
higher O
affinity O
to O
CYP3A4 B-Gene
than O
the O
acid O
(K(m): O
para-hydroxy B-Chemical
atorvastatin, B-Chemical
25.6 O
+ O
- O
5.0 O
microM; O
para-hydroxy B-Chemical
atorvastatin B-Chemical
lactone, B-Chemical
1.4 O
+ O
- O
0.2 O
microM; O
ortho-hydroxy B-Chemical
atorvastatin, B-Chemical
29.7 O
+ O
- O
9.4 O
microM; O
and O
ortho-hydroxy B-Chemical
atorvastatin B-Chemical
lactone, B-Chemical
3.9 O
+ O
- O
0.2 O
microM). O
Compared O
with O
atorvastatin B-Chemical
acid, I-Chemical
CYP-dependent O
metabolism O
of O
atorvastatin B-Chemical
lactone B-Chemical
to O
its O
para-hydroxy O
metabolite O
was O
83-fold O
higher O
[formation O
CL(int) O
(V(max) O
K(m)): O
lactone B-Chemical
2949 O
+ O
- O
3511 O
versus O
acid O
35.5 O
+ O
- O
48.1 O
microl. O
min(-1). O
mg(-1)] O
and O
to O
its O
ortho-hydroxy O
metabolite O
was O
20-fold O
higher O
(CL(int): O
lactone B-Chemical
923 O
+ O
- O
965 O
versus O
acid O
45.8 O
+ O
- O
59. O
1 O
microl. O
min(-1). O
mg(-1)). O
Atorvastatin B-Chemical
lactone B-Chemical
inhibited O
the O
metabolism O
of O
atorvastatin B-Chemical
acid I-Chemical
by O
human B-Species
liver O
microsomes O
with O
an O
inhibition O
constant O
(K(i)) O
of O
0.9 O
microM O
while O
the O
K(i) O
for O
inhibition O
of O
atorvastatin B-Chemical
by O
atorvastatin B-Chemical
lactone B-Chemical
was O
90 O
microM. O
Binding O
free O
energy O
calculations O
of O
atorvastatin B-Chemical
acid I-Chemical
and O
atorvastatin B-Chemical
lactone B-Chemical
complexed O
with O
CYP3A4 B-Gene
revealed O
that O
the O
smaller O
desolvation O
energy O
of O
the O
neutral O
lactone B-Chemical
compared O
with O
the O
anionic O
acid O
is O
the O
dominant O
contribution O
to O
the O
higher O
binding O
affinity O
of O
the O
lactone B-Chemical
rather O
than O
an O
entropy O
advantage. O
Because O
atorvastatin B-Chemical
lactone B-Chemical
has O
a O
significantly O
higher O
metabolic O
clearance O
and O
the O
lactone B-Chemical
is O
a O
strong O
inhibitor O
of O
atorvastatin B-Chemical
acid I-Chemical
metabolism, O
it O
can O
be O
expected O
that O
metabolism O
of O
the O
lactone B-Chemical
is O
the O
relevant O
pathway O
for O
atorvastatin B-Chemical
elimination O
and O
drug O
interactions. O
We O
hypothesize O
that O
most O
of O
the O
open O
acid O
metabolites O
present O
in O
human B-Species
plasma O
are O
generated O
by O
interconversion O
of O
lactone B-Chemical
metabolites. O